NEW YORK (PIX11) — A Brooklyn-based company now has the green light to sell a potentially life-saving gel that stops bleeding on contact. Traumagel has been cleared by the FDA for use by medical ...
The U.S. Food and Drug Administration (FDA) has approved a novel treatment that is designed to stop severe bleeding in a matter of seconds. TRAUMAGEL — made by Cresilon Inc., a Brooklyn-based ...
NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, announced the U.S. commercial launch of ...
NEW YORK, March 2, 2026 /PRNewswire/ -- Cresilon announced its revolutionary hemostatic gel TRAUMAGEL ® has received an Innovative Technology contract from Vizient ® the nation's largest ...
The Cobb County Fire Department was the first agency in the country to use the revolutionary new gel that quickly stops bleeding. The plant-based gel can control severe bleeding in seconds, according ...
NEW YORK, March 12, 2026 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced that a retrospective ...
(MENAFN- PR Newswire) Hemostatic gel designed to control moderate to severe bleeding in seconds and save lives NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based ...
Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Custom Feed: See the stories that matter most to you. Smart Alerts: Get notified about major news as it happens. Update ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results